Nanovaccine for eliciting bnabs against HIV-1
Active Definitive Contract Awarded Last action
- Contract number
- 75N93024C00019
- Awardee
-
Neovaxsyn Inc. UEI EHMTBALCKFE8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,000,000
Award facts
- Opportunity
-
- SBIRPHS20201 Solicitation number
- Contract value 100% obligated
- $2,000,000.00 Current and potential, with all options
- Completion date 58% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 2 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Ames, IA 50011, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $2,000,000 |
About this award
The National Institute of Allergy and Infectious Diseases awarded a $2 million definitive contract to Neovaxsyn Inc. for development of a nanovaccine to elicit broadly neutralizing antibodies against HIV-1 on July 1, 2024, under a total small business set-aside.
Neovaxsyn is a minority-owned, self-certified small disadvantaged business. Place of performance is Ames, Iowa. The contract is priced firm fixed price with an ultimate completion date of June 30, 2028.
In FY2024, the contract invoiced $167 thousand across 0.2 FTEs and 315 contractor hours, reflecting a derived government-paid rate of $529.10 per hour. The prime self-performed all reported labor with no subcontractors.
Quick answers
Who was awarded contract 75N93024C00019?
75N93024C00019 was awarded to Neovaxsyn Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 1, 2024.
How much is contract 75N93024C00019 worth?
The government has obligated $2,000,000 on 75N93024C00019.
Was contract 75N93024C00019 competed?
The extent of competition for 75N93024C00019 was full and open competition after exclusion of sources. The government received 2 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award